| 摘要 |
It is intended to provide a novel diagnostic means and pharmaceutical compositions by finding out and providing a novel neurolysin-like substance in humans, analyzing the function, localization, etc. of the novel neurolysin-like substance in humans, clarifying the role of this substance in vivo and thus controlling its function. A novel neurolysin-like substance having an activity of degrading a synthetic substrate Mcc-Pro-Leu-Gly-Pro-D-Lys(DNP)-OH is found out. |
